Editors


Dr. Luc Duchesne

About Dr. Luc Duchesne

Dr. Luc C. Duchesne is a Speaker and Author with a PhD in Biochemistry. With three decades of scientific and business experience, he has published 85 scientific papers, and has recently published his first novel, "The Moose Motel: A Tale of Golden Revenge". The Founder and CEO for GSN DreamWorks Inc. based in Ottawa, Luc is a regular columnist for InvestorIntel.

187 InvestorIntel Articles By Dr. Luc Duchesne

image_pdfimage_print

Aurora Cannabis makes strategic investment into the world’s largest producers of hemp products


September 08, 2017
| September 08, 2017 | 2 Comments

Hempco Food and Fiber Inc. (“Hempco”) (TSXV: HEMP) announced the terms of an agreement with Aurora Cannabis Inc. (Aurora) (TSXV: […]


InvestorIntel dots the “’I” of InvestorIntel


August 23, 2017
| August 23, 2017 | 1 Comment

InvestorIntel is pleased to report that it has been granted a trademark for its “i” logo from the United States […]


Sayona Mining in $30 billion race for lithium battery market


August 22, 2017
| August 22, 2017

Sayona Mining Limited (ASX: SYA) “Sayona” reported on its exploration programs in support of its Updated Pre-Feasibility Study of the […]


Road to Ring of Fire news lights market activity


August 21, 2017
| August 21, 2017

Noront Resources’ (TSXV: NOT) shares jumped 30% to $0.43 today in response to an announcement by Premier Kathleen Wynne that […]


Scythian to treat the secondary effects of traumatic brain injuries with cannabinoids


August 14, 2017
| August 14, 2017 | 3 Comments

Scythian BioSciences Corp. (TSXV: SCYB), which began trading on the TSXV last week under the symbol SCYB, is developing cannabinoid-based drugs to […]


We need niobium, Mr. President


August 10, 2017
| August 10, 2017 | 1 Comment

NioCorp Developments Ltd. (TSX: NB | OTCQX: NIOBF) last week announced Governor Pete Ricketts (R-NE) has nominated the Elk Creek Superalloy […]